In 2023, France's share of the world's top 10% most-cited scientific publications in pulmonary and respiratory medicine stood at approximately 9.80%. The forecasts indicate a gradual increase, with values reaching 10.61% by 2028. The annual year-on-year growth from 2024 to 2028 shows a steady upward trend, highlighting a consistent augmentation in France’s global citation impact in this medical domain. The compound annual growth rate (CAGR) over these five years will solidify France's advancing position in the research landscape.

Future trends to watch for include:

Increasing collaboration between French institutions and global partners, enhancing research output and impact.
Potential policy shifts or investments in healthcare R&D by France's government.
Breakthroughs in the field of pulmonary and respiratory medicine that might further elevate citation rates.